Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.24 AUD | 0.00% | +4.35% | +2.13% |
28/02 | Transcript : Capitol Health Limited, H1 2024 Earnings Call, Feb 29, 2024 | |
28/02 | Capitol Health Posts 20% Rise in H1 FY24 Revenue, Returns to Profit | MT |
Sales 2024 * | 238M 156M 12.99B | Sales 2025 * | 253M 165M 13.77B | Capitalization | 256M 167M 13.93B |
---|---|---|---|---|---|
Net income 2024 * | 8M 5.23M 436M | Net income 2025 * | 14M 9.14M 762M | EV / Sales 2024 * | 1.6 x |
Net Debt 2024 * | 125M 81.7M 6.81B | Net Debt 2025 * | 123M 80.16M 6.68B | EV / Sales 2025 * | 1.5 x |
P/E ratio 2024 * |
29.7
x | P/E ratio 2025 * |
18
x | Employees | 1,000 |
Yield 2024 * |
4.03% | Yield 2025 * |
4.13% | Free-Float | 92.64% |
Latest transcript on Capitol Health Limited
1 week | +4.35% | ||
3 months | -2.04% | ||
6 months | +23.08% | ||
Current year | +2.13% |
Managers | Title | Age | Since |
---|---|---|---|
Justin Walter
CEO | Chief Executive Officer | - | 06/19/06 |
Melanie Leydin
SEC | Corporate Secretary | 51 | 10/17/10 |
Members of the board | Title | Age | Since |
---|---|---|---|
Andrew Demetriou
CHM | Chairman | 63 | 17/14/17 |
Laura McBain
BRD | Director/Board Member | - | 01/21/01 |
Justin Walter
CEO | Chief Executive Officer | - | 06/19/06 |
Date | Price | Change | Volume |
---|---|---|---|
26/24/26 | 0.24 | 0.00% | 2,060,613 |
24/24/24 | 0.24 | 0.00% | 2,176,980 |
23/24/23 | 0.24 | +9.09% | 6,144,944 |
22/24/22 | 0.22 | -4.35% | 8,233,838 |
19/24/19 | 0.23 | +2.22% | 433,355 |
Delayed Quote Australian S.E., April 26, 2024 at 11:40 am IST
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+2.13% | 167M | |
-17.89% | 8.25B | |
+39.20% | 3.57B | |
-39.11% | 2.46B | |
-8.06% | 2.46B | |
-7.35% | 2.38B | |
-12.61% | 1.81B | |
-19.01% | 1.55B | |
-40.66% | 1.21B | |
+7.56% | 1.11B |
- Stock Market
- Equities
- CAJ Stock